Healthcare and Pharmaceuticals industry

Global CAR T Cell Therapy Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Report Description
CAR T cell therapy has been a major buzzword for a while, owing to its effectiveness in treating blood cancer. These are the genetically engineered receptors that targets surface molecules in patient's immune system. T cells are collected from patients and are genetically engineered in the laboratory in order to multiply them by millions. These T cells are further injected in patients to offer immunity and guard against recurrence of tumorous cells.

Market Dynamics
CAR T cell therapy is expected to be a game changer post its commercialization creating revenue opportunities for players in the CAR T cell therapy market. Moreover, it is expected to help with effective diagnosis of acute lymphoblastic leukemia (ALL) in B cells of children. Introduction of the drug is expected to be especially beneficial for leukemia patients. According to the U.S. National Cancer Institute, over 340,000 people in the U.S., suffered from leukemia in 2015, with an estimated 1.5% of the population in the country expected to be detect with leukemia once in their lifetime. Growing prevalence rate and increasing demand for effective treatment modalities is expected to pave way for market growth over the forecast period.

The CAR T cell therapy market is expected to be highly consolidated over the next few years, with the three major players accounting for around half of the overall market revenue share. This novel therapeutic application is expected to create lucrative profit margins for industry players across the value chain, ranging from manufacturers to distributors and end-use hospitals.

Market Taxonomy
This report segments the CAR T cell therapy market on the basis of antigen type, and therapeutic applications. On the basis of antigen, CAR T cell therapy market is segmented as CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, EGFRvlll, and others.
On the basis of therapeutic applications, CAR T cell therapy market is segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, non-hodgkin leukemia, multiple myeloma, pancreatic cancer, neuroblasta, breast cancer, acute myeloid leukemia, hepatocellular carcinoma, colorectal cancer, and other therapeutic applications.

Key features of the study:
• This report provides in-depth analysis of the CAR T cell therapy market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017 - 2028)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• The report takes into account critical limiting factors such as accuracy issues and need for calibrating the device several times a day while analyzing the market value and growth (%) during the forecast period
o It includes insights on population dynamics, number of dental clinic centers, and demand for CAR T Cell Therapy across the globe.
• It profiles leading players in the global CAR T Cell Therapy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans
• Key companies covered as a part of this study include Juno Therapeutics, Kite Pharma Inc., Novartis International AG, Bellicum Pharmaceuticals Inc., Celgene Corporation, and Cellectis.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, technology upgrade, market expansion, and marketing tactics
• The global CAR T Cell Therapy market report caters to various stakeholders in this industry, including investors, raw material manufacturer, contract manufacturer, device manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the CAR T Cell Therapy market.
Detailed Segmentation:
• Global CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Global CAR T Cell Therapy Market, By Therapeutic Application:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
• Global CAR T Cell Therapy Market, By Geography:
o North America
• North America CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• North America CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
o Europe
• Europe CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Europe CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
o Asia Pacific
• Asia Pacific CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Asia Pacific CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
• Latin America
• Latin America CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Latin America CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
o Middle East
• Middle East CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Middle East CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
o Africa
• Africa CAR T Cell Therapy Market, By Targeted Antigen:
o CD 19
o CD 20
o GD2
o CD22
o CD30
o CD33
o HER1
o HER2
o Meso
o EGFRvlll
o Others
• Africa CAR T Cell Therapy Market, By Technique:
o Acute Lymphocytic Leukemia
o Chronic Lymphocytic Leukemia
o Non Hodgkin Leukemia
o Multiple Myeloma
o Pancreatic Cancer
o Neuroblasta
o Breast Cancer
o Acute Myeloid Leukemia
o Hepatocellular Carcinoma
o Colorectal Cancer
o Others
• Company Profiles
o Novartis International AG *
o Company Overview
o Product Portfolio
o Financial Performance
o Key Strategies
o Recent Developments
o Future Plans
o Kite Pharma Inc.
o Juno Therapeutics
o Bellicum Pharmaceuticals, Inc.
o Celgene Corporation
o Cellectis

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet By Targeted Antigen
o Market Snippet By Therapeutic Application
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Regulatory Scenario
o Industry Trend
o Epidemiology/Prevalence/Incidence
o Merger and Acquisitions
o New Product Approvals/Launch
4. Global Car T Cell Therapy Market, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, 2017 - 2028
o Segment Trends
o CD 19
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o CD 20
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o GD2
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o CD22
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o CD30
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o CD33
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o HER1
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o HER2
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Meso
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o EGFRvlll
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
5. Global Car T Cell Therapy Market, By Therapeutic Application, 2017 - 2028 (USD Million)
o Introduction
o Market Share Analysis, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, 2017 - 2028
o Segment Trends
o Acute Lymphocytic Leukemia
o Introduction
o Market Share Analysis, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, 2017 - 2028
o Chronic Lymphocytic Leukemia
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Non Hodgkin Leukemia
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Multiple Myeloma
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Pancreatic Cancer
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Neuroblasta
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Breast Cancer
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Acute Myeloid Leukemia
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Hepatocellular Carcinoma
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Colorectal Cancer
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-O-Y Growth, 2017 - 2028, (US$ Million)
6. Global Car T Cell Therapy Market, By Regions, 2017 - 2028 (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, For Regions, 2017 - 2028
o North America
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Europe
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Asia Pacific
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Latin America
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Africa
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
o Middle East
o Market Share Analysis, By Segments, 2017 and 2028 (%)
o Y-O-Y Growth Analysis, By Segments, 2017 - 2028
o Market Size and Forecast, By Targeted Antigen, 2017 - 2028 (US$ Million)
o Market Size and Forecast, By Therapeutic Application, 2017 - 2028 (US$ Million)
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
o Novartis International AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Kite Pharma Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Juno Therapeutics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Bellicum Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Celgene Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Cellectis
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 90 market data tables and 40 figures on "Car T Cell Therapy Market - Global forecast to 2024".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.